Pradžia › Šlapimo pūslės vėžys › Ohio › Cleveland
Šlapimo pūslės vėžys klinikiniai tyrimai Cleveland, OH
18 tyrimai dėl Šlapimo pūslės vėžys ieško dalyvių vietose Cleveland ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Renkami dalyviai1 fazė
- University Hospitals Cleveland Medical Center, Cleveland
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Renkami dalyviai1/2 fazė
- Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Renkami dalyviai2 fazė
- Cleveland Clinic - Oncology Department, Cleveland
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Renkami dalyviai2 fazė
- Cleveland Clinic Taussig Cancer Center, Cleveland
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Renkami dalyviai2 fazė
- MetroHealth Medical Center, Cleveland
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Renkami dalyviai1/2 fazė
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Renkami dalyviai1 fazė
- University Hospitals Cleveland Medical Center, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Renkami dalyviaiStebimasis tyrimas
- Cleveland Clinic, Cleveland
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Renkami dalyviai2 fazė
- Cleveland Clinic, Cleveland
The Vanguard Study: Testing a New Way to Screen for Cancer
Renkami dalyviaiLaukiami sveiki savanoriai
- Louis Stokes Cleveland VA Medical Center, Cleveland
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Renkami dalyviai2 fazė
- Cleveland Clinic Main Campus, Cleveland, Cleveland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Renkami dalyviai3 fazė
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · už 10 mylių
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · už 22 mylių
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Renkami dalyviai2/3 fazė
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · už 12 mylių
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Renkami dalyviai3 fazė
- Research Site, Cleveland
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Renkami dalyviai2 fazė
- University Hospitals Cleveland Medical Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Renkami dalyviaiStebimasis tyrimas
- Massive Bio SYNERGY-AI site, Mayfield Heights · už 12 mylių
Šlapimo pūslės vėžys tyrimai kituose miestuose
- New York City, NY35 tyrimai
- Nashville, TN31 tyrimas
- Houston, TX31 tyrimas
- Dallas, TX27 tyrimai
- Boston, MA26 tyrimai
- Washington, DC26 tyrimai
- Los Angeles, CA24 tyrimai
- Baltimore, MD24 tyrimai
- St. Louis, MO22 tyrimai
- Philadelphia, PA21 tyrimas
- Seattle, WA21 tyrimas
- Edison, NJ21 tyrimas
Kiti tyrimai Cleveland
- Nedidelinių ląstelių plaučių vėžys43 tyrimai
- Vėžys (visų tipų)36 tyrimai
- Krūties vėžys35 tyrimai
- Prostatos vėžys34 tyrimai
- Širdies nepakankamumas33 tyrimai
- Metastatinis vėžys30 tyrimai
- Kiaušidžių vėžys30 tyrimai
- Plaučių vėžys26 tyrimai
- Storosios ir tiesiosios žarnos vėžys24 tyrimai
- Širdies ir kraujagyslių ligos22 tyrimai
- Endometrio vėžys20 tyrimai
- Ūmi mieloidinė leukemija20 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.